RNAi pioneer and Nobel Laureate Craig Mello will chair this year’s Dr. Paul Janssen Award for Biomedical Research Symposium.
The symposium is entitled, “Novel Anti-Cytokine Therapies,” and will take place at the New York Academy of Scienceson Sept. 10. The event will honor the winners of the 2008 Dr. Paul Janssen Award for Biomedical Research, Marc Feldman and Ravinder Maini, who discovered tumor necrosis factor-alpha as a target for rheumatoid arthritis and other inflammatory diseases.
Established by Johnson & Johnson in 2004 and given every two years, the award honors Paul Janssen, who founded Janssen Pharmaceutical in 1953 prior to its acquisition by J&J. The award includes a $100,000 prize and recognizes the work of individuals who have “made a significant, transformational contribution toward the improvement of human health,” according to J&J.
Mello was on the selection committee for this year’s award.